PembrolizumabFulminant type 1 diabetes: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70041-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：380 / 380

相关论文

共 50 条

[1] PembrolizumabFulminant type 1 diabetes: case report
Reactions Weekly, 2019, 1746 (1) : 161 - 161
[2] Ipilimumab/pembrolizumabFulminant type 1 diabetes: case report
Reactions Weekly, 2016, 1603 (1) : 157 - 157
[3] PembrolizumabFulminant type 1 diabetes mellitus and ketoacidosis: case report
Reactions Weekly, 2023, 1957 (1) : 448 - 448
[4] PembrolizumabFulminant type-1 diabetes mellitus: case report
Reactions Weekly, 2019, 1761 (1) : 297 - 297
[5] PembrolizumabFulminant type I diabetes mellitus: case report
Reactions Weekly, 2021, 1851 (1) : 284 - 284
[6] PembrolizumabFulminant type I diabetes mellitus and destructive thyroiditis: case report
Reactions Weekly, 2019, 1755 (1) : 260 - 260
[7] Nivolumab/pembrolizumabFulminant type 1 diabetes: 4 case reports
Reactions Weekly, 2018, 1707 (1) : 213 - 213
[8] PembrolizumabFulminant diabetes and pulmonary toxicity: case report
Reactions Weekly, 2020, 1807 (1) : 162 - 162
[9] Ipilimumab/nivolumab/pembrolizumabFulminant type 1 diabetes: 4 case reports
Reactions Weekly, 2017, 1637 (1) : 122 - 122
[10] PembrolizumabFulminant myocarditis: case report
Reactions Weekly, 2018, 1715 (1) : 214 - 214

← 1 2 3 4 5 →